Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Pharming raises €14.7 million in shares and warrants deal

Country: Netherlands

Pharming Group NV has raised €14.7 million with a private placement of its shares and warrants with existing institutional shareholders to support the expected launch of Ruconest, a treatment for hereditary angioedema.

Read more

TxCell secures €16.2 million in IPO

Country: France

The French biotechnology company TxCell SA has secured €16.2 million in an initial public offering of its shares on the Euronext stock exchange in Paris, enabling it to advance the clinical development of its lead product Ovasave for refractory Crohn’s disease.

Read more

Boehringer Ingelheim sees flat sales in 2014

Country: Germany

Read more

New US indication for Arzerra

Country: United Kingdom

Read more

FDA approves third allergy tablet

Country: United States

Read more

New UK trial paradigm for lung cancer

Country: United Kingdom

Read more

Actelion expands its PAH franchise in first quarter

Country: Switzerland

Read more

OxThera get funding for orphan project

Country: Sweden

Read more

BioAlliance and Topotarget to merge

Country: France

Read more

Wilson Therapeutics gets B-round financing

Country: Sweden

Read more

FDA approves second allergy tablet

Country: United States

Read more

FDA approves albiglutide

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Why the UK is building cell therapy capacity by Keith Thompson

CommentaryKeithThompsonApr14.pdf

Highlights of the April 2014 MedNous issue

The April 2014 MedNous features:

Latest Mednous cover
  • Business Strategy
    Revolution afoot
    for allergy therapies
  • Interview
    Ewan Birney discusses
    Big Data and drug
    target validation
  • Commentary
    How drug development
    can be shortened
    By Christian Grøndahl and Glenn A Friedrich
  • Commentary
    Why the UK is building cell therapy capacity
    By Keith Thompson
  • Markets
    European biotechs gain European IPO window opens

The latest MedNous journal. Subscribe to download.

Recent Appointments